Envarsus Tablet, Extended Release
Pricing Report NDC 68992-3010-1

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Envarsus Xr (NDC 68992-3010-1) is $6.19040 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 23, 2022.

As a a human prescription drug provided by Veloxis Pharmaceuticals, Inc, this medication is distributed in a 1 POUCH in 1 CARTON / 1 BOTTLE in 1 POUCH / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.19040
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 23, 2022
Billable Units
1 EA
Estimated Package Price
$6.19
Data Status
As of Apr 12, 2023
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
68992-3010-1
Description
1 POUCH in 1 CARTON / 1 BOTTLE in 1 POUCH / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2021, the NADAC wholesale price for (NDC ) has moved within a range of $5.58331 to $6.19040 per EA. Over this 1 year and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.5833 - $6.1904
Market Volatility
10.87% Variance
Latest Trend
3.50%
Date Unit Price Unit Source Method Rate
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Dec 23, 2022 $6.19040 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jun 24, 2022 $5.98098 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Dec 17, 2021 $5.77873 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 20, 2021 $5.58331 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 20, 2021 $5.58331 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 20, 2021 $5.58331 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 20, 2021 $5.58331 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026